GIP (Glucose-Dependent Insulinotropic Polypeptide) GIP is the second gut hormone targeted by Mounjaros dual mechanism
The peptide, BPC 157, which is one of the hottest, uh, compounds out there in terms of, uh, recovery and wellness
Biological Activities Observed in Studies Selective inhibition of nicotinamide N-methyltransferase (NNMT) Increased intracellular nicotinamide availability Modulation of NAD metabolic pathways Enhanced mitochondrial energy metabolism in experimental models Reduced adipocyte hypertrophy in preclinical studies Altered lipid metabolism and fatty acid utilization Investigation of cellular methylation pathways Potential influence on metabolic flexibility Evaluation of adipose tissue remodeling mechanisms Research applications in aging and regenerative biology Current evidence remains limited, and further well-controlled clinical studies are required to establish long-term efficacy and safety in humans
That said, Wegovy is FDA-approved and widely prescribed for weight loss with excellent clinical responses, while retatrutide is still an investigational drug only available through clinical trials and its long-term safety and tolerability are still being studied
It stimulates the pituitary gland to produce and release more natural HGH
Shakeri, A., Tabibi, H., and Hedayati, M
00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)
